Ditte M. Karpf

456 total citations
16 papers, 268 citations indexed

About

Ditte M. Karpf is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ditte M. Karpf has authored 16 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ditte M. Karpf's work include Hemophilia Treatment and Research (12 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Platelet Disorders and Treatments (7 papers). Ditte M. Karpf is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Platelet Disorders and Treatments (7 papers). Ditte M. Karpf collaborates with scholars based in Denmark, United States and Norway. Ditte M. Karpf's co-authors include Anette Müllertz, Dimitrios G. Fatouros, F. S. Nielsen, Mirella Ezban, René Holm, H. Pelzer, Torben Elm, Marianne Kjalke, Henning Gjelstrup Kristensen and Mikael Tranholm and has published in prestigious journals such as Blood, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Ditte M. Karpf

16 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ditte M. Karpf Denmark 10 124 89 43 41 39 16 268
Angelica Dorantes United States 7 91 0.7× 56 0.6× 79 1.8× 168 4.1× 10 0.3× 13 325
Jiexin Deng United States 9 21 0.2× 85 1.0× 72 1.7× 116 2.8× 22 0.6× 14 315
Julie K. Rhie United States 9 10 0.1× 59 0.7× 77 1.8× 54 1.3× 16 0.4× 12 208
M. J. van Maanen Netherlands 10 21 0.2× 43 0.5× 140 3.3× 117 2.9× 17 0.4× 14 358
Lori L. Bostrom United States 9 89 0.7× 15 0.2× 34 0.8× 107 2.6× 29 0.7× 10 332
Shuaige Wang United States 8 103 0.8× 19 0.2× 16 0.4× 80 2.0× 37 0.9× 9 330
Joseph Cacciola United States 8 111 0.9× 14 0.2× 39 0.9× 80 2.0× 38 1.0× 10 304
Keith Eagen United States 10 72 0.6× 10 0.1× 14 0.3× 51 1.2× 41 1.1× 15 218
Isabelle Solassol France 10 26 0.2× 10 0.1× 84 2.0× 103 2.5× 14 0.4× 17 328
Yasumasa Sugita Japan 10 46 0.4× 8 0.1× 37 0.9× 97 2.4× 22 0.6× 27 294

Countries citing papers authored by Ditte M. Karpf

Since Specialization
Citations

This map shows the geographic impact of Ditte M. Karpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ditte M. Karpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ditte M. Karpf more than expected).

Fields of papers citing papers by Ditte M. Karpf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ditte M. Karpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ditte M. Karpf. The network helps show where Ditte M. Karpf may publish in the future.

Co-authorship network of co-authors of Ditte M. Karpf

This figure shows the co-authorship network connecting the top 25 collaborators of Ditte M. Karpf. A scholar is included among the top collaborators of Ditte M. Karpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ditte M. Karpf. Ditte M. Karpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bloem, Esther, Ditte M. Karpf, Peder Lisby Nørby, et al.. (2018). Factor VIII with a 237 amino acid B‐domain has an extended half‐life in F8‐knockout mice. Journal of Thrombosis and Haemostasis. 17(2). 350–360. 4 indexed citations
2.
Rode, Frederik, Kasper Almholt, Maj Petersen, et al.. (2018). Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model. Journal of Thrombosis and Haemostasis. 16(6). 1141–1152. 8 indexed citations
3.
Øie, Cristina Ionica, Kirstine Roepstorff, C.F. Behrens, et al.. (2016). High‐affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats. Journal of Thrombosis and Haemostasis. 14(9). 1803–1813. 1 indexed citations
4.
Johansson, Linda, Ditte M. Karpf, Lene Hansen, H. Pelzer, & Egon Persson. (2011). Activation peptides prolong the murine plasma half-life of human factor VII. Blood. 117(12). 3445–3452. 11 indexed citations
5.
Karpf, Ditte M., Marianne Kjalke, L. Thim, et al.. (2011). Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs. Haemophilia. 17(5). e963–8. 12 indexed citations
6.
Christensen, Erik I., et al.. (2011). In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver. Thrombosis Research. 127(4). 356–362. 13 indexed citations
7.
Elm, Torben, Ditte M. Karpf, H. Pelzer, et al.. (2011). Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice. Haemophilia. 18(1). 139–145. 31 indexed citations
8.
Karpf, Ditte M., Brit B. Sørensen, Mette B. Hermit, et al.. (2011). Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa. Thrombosis Research. 128(2). 191–195. 15 indexed citations
9.
Kjalke, Marianne, Ditte M. Karpf, Ida Hilden, et al.. (2011). High Affinity Binding of FVIII to VWF Is Not Required for the Haemostatic Effect of FVIII In Vivo. Blood. 118(21). 1182–1182. 2 indexed citations
10.
Agersø, Henrik, Niels Rode Kristensen, Ditte M. Karpf, et al.. (2011). Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs. European Journal of Pharmaceutical Sciences. 42(5). 578–583. 5 indexed citations
11.
Petersen, Lars C., Ditte M. Karpf, Henrik Agersø, et al.. (2010). Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin. British Journal of Haematology. 152(1). 99–107. 15 indexed citations
12.
Elm, Torben, Mirella Ezban, Thomas N. Krogh, et al.. (2009). Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Thrombosis and Haemostasis. 101(5). 818–826. 25 indexed citations
13.
Fatouros, Dimitrios G., Ditte M. Karpf, F. S. Nielsen, & Anette Müllertz. (2007). Clinical studies with oral lipid based formulations of poorly soluble compounds.. PubMed. 3(4). 591–604. 81 indexed citations
14.
Karpf, Ditte M., et al.. (2005). Effect of different surfactants in biorelevant medium on the secretion of a lipophilic compound in lipoproteins using Caco-2 cell culture. Journal of Pharmaceutical Sciences. 95(1). 45–55. 13 indexed citations
15.
Karpf, Ditte M., René Holm, Henning Gjelstrup Kristensen, & Anette Müllertz. (2004). Influence of the Type of Surfactant and the Degree of Dispersion on the Lymphatic Transport of Halofantrine in Conscious Rats. Pharmaceutical Research. 21(8). 1413–1418. 27 indexed citations
16.
Karpf, Ditte M., et al.. (2003). Effect of ketoprofen and its enantiomers on the renal disposition of methotrexate in the isolated perfused rat kidney. Journal of Pharmacy and Pharmacology. 55(12). 1641–1646. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelica Dorantes Breakdown of academic impact, for papers by Jiexin Deng Breakdown of academic impact, for papers by Julie K. Rhie Breakdown of academic impact, for papers by M. J. van Maanen Breakdown of academic impact, for papers by Lori L. Bostrom Breakdown of academic impact, for papers by Shuaige Wang Breakdown of academic impact, for papers by Joseph Cacciola Breakdown of academic impact, for papers by Keith Eagen Breakdown of academic impact, for papers by Isabelle Solassol Breakdown of academic impact, for papers by Yasumasa Sugita
Rankless by CCL
2026